HIV-Specific T Cells Can Be Generated against Non-escaped T Cell Epitopes with a GMP-Compliant Manufacturing Platform
Open Access
- 11 October 2019
- journal article
- research article
- Published by Elsevier BV in Molecular Therapy - Methods & Clinical Development
- Vol. 16, 11-20
- https://doi.org/10.1016/j.omtm.2019.10.001
Abstract
No abstract availableKeywords
Funding Information
- BELIEVE Martin Delaney Collaboratory
- NIAID (UM1AI26617)
- NIDA
- NIMH
- NINDS (P01 CA148600, R01 HL132791-0)
This publication has 42 references indexed in Scilit:
- Anti-HIV designer T cells progressively eradicate a latently infected cell line by sequentially inducing HIV reactivation then killing the newly gp120-positive cellsVirology, 2013
- Stimulation of HIV-1-Specific Cytolytic T Lymphocytes Facilitates Elimination of Latent Viral Reservoir after Virus ReactivationImmunity, 2012
- HIV-Specific Cytolytic CD4 T Cell Responses During Acute HIV Infection Predict Disease OutcomeScience Translational Medicine, 2012
- HIV-specific CD8+ T cells from HIV+ individuals receiving HAART can be expanded ex vivo to augment systemic and mucosal immunity in vivoBlood, 2011
- Long-term outcome of EBV-specific T-cell infusions to prevent or treat EBV-related lymphoproliferative disease in transplant recipientsBlood, 2010
- The first T cell response to transmitted/founder virus contributes to the control of acute viremia in HIV-1 infectionThe Journal of Experimental Medicine, 2009
- Comprehensive Epitope Analysis of Human Immunodeficiency Virus Type 1 (HIV-1)-Specific T-Cell Responses Directed against the Entire Expressed HIV-1 Genome Demonstrate Broadly Directed Responses, but No Correlation to Viral LoadJournal of Virology, 2003
- A Phase II Randomized Study of HIV-Specific T-Cell Gene Therapy in Subjects with Undetectable Plasma Viremia on Combination Antiretroviral TherapyMolecular Therapy, 2002
- Decay Kinetics of Human Immunodeficiency Virus-Specific CD8+T Cells in Peripheral Blood after Initiation of Highly Active Antiretroviral TherapyJournal of Virology, 2001
- In vivo fate of HIV-1-infected T cells: Quantitative analysis of the transition to stable latencyNature Medicine, 1995